Skip to main content

Sponsored By

Lilly
Interview with the Innovators

Improving Abemaciclib Tolerability: Insights From the TRADE Dose-Escalation Study

Videos
Jamie Carroll, APRN, CNP, MSN
Assistant Professor, Oncology
Mayo Clinic
Rochester, MN
In this sixth installment, Ms Carroll discusses the TRADE study with abemaciclib and emphasizes the importance of individualized patient care, clear communication about dosing goals, and teamwork among healthcare providers to implement dose escalation effectively. This strategy aims to address patient concerns about side effects while ensuring adherence to the full treatment plan.

Related Items